NCT04393298 2025-05-29A Study to Assess the Safety, Pharmacokinetics and Anti Tumor Activity of UCB6114 Administered Intravenously to Participants With Advanced Solid TumorsUCB PharmaPhase 1/2 Completed93 enrolled 28 charts